Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarker.
Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarker.
复制标题
DOI:
10.1016/j.semnephrol.2010.09.007
复制
发表时间:
2010-11
影响因子:
3.3
通讯作者:
Humphreys, Benjamin D.
中科院分区:
文献类型:
--
作者:
Robinson, Emily S.;Khankin, Eliyahu V.;Karumanchi, S. Ananth;Humphreys, Benjamin D.
Drugs that inhibit the vascular endothelial growth factor (VEGF) signaling pathway are a rapidly growing chemotherapy class for treatment of solid tumors. This “targeted therapy” is more specific than traditional chemotherapy, causing fewer side effects. However, VEGF-targeted therapies cause hypertension in 30 – 80% of patients. Unlike traditional “off-target” side effects, hypertension is a mechanism-dependent, “on-target” toxicity – reflecting effective inhibition of the VEGF signaling pathway rather than non-specific effects on unrelated signaling pathways. In this article, we review current understanding of the mechanisms of VEGF-targeted therapy-induced hypertension, discuss similarities with preeclampsia, review implications for therapy of this increasingly common clinical problem and discuss the potential use of blood pressure rise as a biomarker for proper drug dosing and effective VEGF pathway inhibition.
登录
查看更多内容
DOI:
10.1161/01.atv.17.11.2793
发表时间:
1997-11-01
影响因子:
8.7
作者:
Horowitz, JR;Rivard, A;Isner, JM
通讯作者:
Isner, JM
影响因子:
3.3
作者:
Mac Gabhann, Feilim;Ji, James W.;Popel, Aleksander S.
通讯作者:
Popel, Aleksander S.
DOI:
10.1152/ajpheart.01277.2005
发表时间:
2006-09-01
影响因子:
4.8
作者:
Gonzalez-Pacheco, Francisco R.;Deudero, Juan J. P.;Caramelo, Carlos
通讯作者:
Caramelo, Carlos
DOI:
10.1152/ajpheart.00542.2005
发表时间:
2006-01-01
影响因子:
4.8
作者:
Baffert, F;Le, T;McDonald, DM
通讯作者:
McDonald, DM
影响因子:
64.8
作者:
Fulton, D;Gratton, JP;Sessa, WC
通讯作者:
Sessa, WC